OP 5.2 – 00070 Characterization of a dual PTPN1/PTPN2 inhibitor to target latent HIV reservoirs

• A. Bosque,
• J.N. Howard,
• T.D. Zaikos,
• C. Levinger,
• E. McMahon,
• H. Takata,
• E. Rivera,
• D.C. Copertino,
• W. Wang,
• M. Sanz-Perez,
• X. Arias-Moreno,
• N. Soriano-Sarabia,
• R. Brad Jones,
• L. Trautmann

Affiliations

A. Bosque

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA

J.N. Howard

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA

T.D. Zaikos

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA

C. Levinger

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA

E. McMahon

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA

H. Takata

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA

E. Rivera

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA

D.C. Copertino

Department of Medicine, Weill Cornell Medical College, New York, USA

W. Wang

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA

M. Sanz-Perez

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA

X. Arias-Moreno

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA

N. Soriano-Sarabia

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA

R. Brad Jones

Department of Medicine, Weill Cornell Medical College, New York, USA

L. Trautmann

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA